Engadget Mobile’s Nokia E71 review
Thursday, June 19th, 2008by Paul Miller, posted Jun 19th 2008 at 4:39PM
They’ve got a bona fide, US 3G-friendly, Nokia E71 over at Engadget Mobile, all gussied up and reviewed for your viewing pleasure. The phone is a serious statement from Nokia, being that company’s first 3G QWERTY device in the States, and the thinnest QWERTY smartphone in existence. Not too shabby for a little Finnish upstart.
- Read
- Permalink
- Email this
- 22 Comments
Filed under: cellphones
While the last Taser study we came across found that the devices were safe and caused only a few trips to the hospital, a joint investigation by CBC News and the Canadian Press has now turned up some decidedly different findings, with about one-third of people shot by Tasers reportedly requiring some form of medical attention. Those numbers were drawn from the Taser-use forms that RCMP officers are required to fill out whenever they draw the device, which revealed that 910 of the 3,226 people shot between 2002 and 2007 had to go to a medical facility, and that “many more” people had minor injuries but never saw a doctor. Needless to say, we somehow suspect this won’t be the last such investigation or study on the matter, especially with the lawsuits flying fast and furiously these days.
Sony Europe president David Reeves has never been one to shy away from making bold statements in the past, and he’s now come out and weighed in on another touchy subject, with him flatly telling attendees at the DevStation conference in London that “there is a piracy problem on the PSP.” What’s more, Reeves went so far as to admit that it “sometimes fuels the growth of hardware sales, but that “on balance”, Sony is “not happy about it.” To that end, Reeves says that Sony will soon be unveiling new ways to combat piracy on the handheld, although he unsurprisingly isn’t getting a whole lot more specific than that at the moment.
There’s certainly no shortage of efforts out there to make glucose monitoring a bit easier for diabetics, but Freedom Meditech is now claiming to have developed one of the least invasive to date and, what’s more, it says it’s actually gearing up to start some clinical trials. That latter bit is apparently possible thanks to a newly formed partnership with Batelle, which is helping to raise the necessary capital, while the former bit got a boost from an arrangement with the University of Toledo, whose technology it is licensing. The key bit, it seems, is that Freedom Meditech’s method involves scanning only the front portion of the eye (or, more specifically, the Aqueous humor where the glucose resides) instead of shining a light on the retina, which some similar methods use. That apparnetly not only delivers results faster, but reduces the risk of any potential long-term safety hazards from repeated laser exposure, which would also make it better suited as a tool for early screening of diabetes.
